City Therapeutics, Inc.
CTY
NASDAQ
Upcoming IPOs
Expected Listing Date: 2026-10-16
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-1.68~-1.50
-
-
855.65M~956.31M
-
2026-09-24
Public Filing
View Prospectus
Pending
Offering
Price Range: 17.00~19.00
Shares to be Issued: 9722.22K
2026-10-15
Offering End Date
Offering Price: Pending
Post IPO Outstanding: 50.33M
2026-10-16
Listed
U.S. IPO Weekly Recap: Biotech IPOs Keep Flowing As Data Center Developer DayOne Joins The Pipeline
Seeking Alpha · 1d ago
About CTY
City Therapeutics Inc is a United States-based company which is primarily engaged in the business activity of operating a biopharmaceutical company. The Company is focusing on engineering small-interfering ribonucleic acid (siRNAs) to enhance ribonucleic acid interference (RNAi)-based therapies. It develops a pipeline of RNAi therapeutics aimed at addressing various disease indications.

Webull offers City Therapeutics, Inc. stock information, including NASDAQ: CTY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTY stock methods without spending real money on the virtual paper trading platform.